The Radiology Business Journal (5/2, Walter) reports, “Adding digital breast tomosynthesis (DBT) to digital mammography (DM) in the prevalent screening round of a breast cancer screening program leads to a reduced recall rate and improved reader confidence.” The findings were published in Clinical Radiology.
Diagnostic Imaging (5/1) reports a retrospective review by researchers at the University of Wisconsin School of Medicine and Public Health, the American College of Radiology, and Stanford University School of Medicine suggests “use of category 4 subdivisions in diagnostic mammography allowed for positive predictive value for biopsies performed (PPV3) to specify malignancy ranges.” The findings were published in Radiology.
Aunt Minnie (5/1, Ridley) reports software that calculates breast density can “perform as well as a radiologist and help identify a woman’s future risk of breast cancer,” particularly for the risk of invasive interval cancers, according to research published May 1 in the Annals of Internal Medicine. After conducting a large case-control study, researchers led by Dr. Karla Kerlikowske of the University of California, San Francisco “concluded that automated and clinical breast density assessment methods yielded comparable results for predicting the risk of cancer detected in subsequent mammography screening and, in particular, the risk of interval cancer,” the article says.
The New York Post (4/30, Steussy) reports “the American College of Radiology and the Society of Breast Imaging are now recommending that women as young as 30 get a risk assessment – such as a genetic test – to determine what kind of formal cancer screening they need.” According to the article, “The new guidelines were announced...as a way to encourage early detection among younger women with a higher risk for breast cancer.”
Aunt Minnie (4/27, Yee) reports screening mammography in women ages 40 to 49 “finds almost 20% more cancers than screening in women ages 50 and older, according to a presentation delivered at the American Roentgen Ray Society (ARRS) meeting in Washington, DC.” The article says the boost in cancer detection “increases the recall rate by only 1.5% and the biopsy rate by 0.1%,” according to researchers led by Dr. Abid Irshad from the Medical University of South Carolina.